IDEXX LABORATORIES INC /DE Quarterly Contract with Customer, Liability, Noncurrent in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Idexx Laboratories Inc /De quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q4 2017 to Q3 2024.
  • Idexx Laboratories Inc /De Contract with Customer, Liability, Noncurrent for the quarter ending September 30, 2024 was $26.8M, a 3.4% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $26.8M -$943K -3.4% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $26.8M -$2.27M -7.81% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $28M -$2.4M -7.87% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $28.5M -$2.33M -7.55% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $27.7M -$7.03M -20.2% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $29.1M -$7.91M -21.4% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $30.4M -$8.79M -22.4% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $30.9M -$10.3M -25% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $34.7M -$5.65M -14% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $37M -$6.23M -14.4% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $39.2M -$5M -11.3% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $41.2M -$4.99M -10.8% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $40.4M -$7.84M -16.2% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $43.2M -$14.6M -25.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $44.2M -$4.81M -9.81% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $46.2M -$2.58M -5.29% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $48.2M -$119K -0.25% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $57.8M +$5.64M +10.8% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $49M -$6.65M -11.9% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $48.7M -$12M -19.7% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $48.3M -$14.2M -22.7% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $52.1M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $55.7M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $60.7M +$25.2M +70.8% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $62.5M Sep 30, 2018 10-Q 2018-11-01
Q4 2017 $35.5M Dec 31, 2017 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.